Comparative in vitro activity of trovafloxacin against Gram-positive and Gram-negative clinical isolates from Argentina

被引：0
|
作者：
Sucari, A
Stepanik, D
Casellas, JM
Tomé, G
Clara, L
Marín, M
Rossi, A
Galas, M
Smayevsky, J
Dufranc, L
Lorenzo, H
de Vedia, L
López, H
机构：
[1] Ctr Infectol, RA-1425 Buenos Aires, DF, Argentina
[2] Sanatorio San Lucas, Buenos Aires, DF, Argentina
[3] Hosp Italiano, Buenos Aires, DF, Argentina
[4] Ctr Estudios Infectol, Buenos Aires, DF, Argentina
[5] Inst Malbran, Buenos Aires, DF, Argentina
[6] CEMIC, Buenos Aires, DF, Argentina
[7] Pfizer Pharmaceut, Buenos Aires, DF, Argentina
来源：
DRUGS | 1999年 / 58卷 / Suppl 2期
关键词：
D O I：
10.2165/00003495-199958002-00059
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：195 / 199
页数：5
相关论文
共 50 条
  • [1] Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina
    Adriana Sucari
    D. Stepanik
    J. M. Casellas
    G. Tomé
    L. Clara
    M. Marín
    A. Rossi
    M. Galas
    J. Smayevsky
    L. Dufranc
    H. Lorenzo
    L. de Vedia
    H. López
    [J]. Drugs, 1999, 58 : 195 - 199
  • [2] Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina
    Lopez, H
    Stepanik, D
    Vilches, V
    Scarano, S
    Sarachian, B
    Mikaelian, G
    Finlay, J
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (04) : 187 - 192
  • [3] Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates
    Cunha, BA
    Qadri, SMH
    Ueno, Y
    Walters, EA
    Domenico, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 29 - 34
  • [4] In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates
    Bonfiglio, G
    Maccarone, G
    Mezzatesta, ML
    Privitera, A
    Carciotto, V
    Santagati, M
    Stefani, S
    Nicoletti, G
    [J]. CHEMOTHERAPY, 1997, 43 (06) : 393 - 399
  • [5] IN-VITRO ACTIVITY OF BIAPENEM AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
    MALANOSKI, GJ
    COLLINS, L
    WENNERSTEN, C
    MOELLERING, RC
    ELIOPOULOS, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 2009 - 2016
  • [6] Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms
    Blondeau, JM
    Laskowski, R
    Bjarnason, J
    Stewart, C
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (01) : 45 - 50
  • [7] Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria
    Odenholt, I
    Cars, T
    Löwdin, E
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (01) : 35 - 43
  • [8] Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates
    Li, Z. X.
    Liu, Y. N.
    Wang, R.
    Li, A. M.
    [J]. CLINICA TERAPEUTICA, 2015, 166 (06): : E374 - E380
  • [9] In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients
    Rolston, Kenneth V. I.
    Jamal, Mohamed A.
    Nesher, Lior
    Shelburne, Samuel A.
    Raad, Issam
    Prince, Randall A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (04) : 416 - 421
  • [10] Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates
    Butler, Michelle M.
    Williams, John D.
    Peet, Norton P.
    Moir, Donald T.
    Panchal, Rekha G.
    Bavari, Sina
    Shinabarger, Dean L.
    Bowlin, Terry L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3974 - 3977
12345